1. Home
  2. TXG vs ACLS Comparison

TXG vs ACLS Comparison

Compare TXG & ACLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 10x Genomics Inc.

TXG

10x Genomics Inc.

HOLD

Current Price

$21.98

Market Cap

2.8B

Sector

Industrials

ML Signal

HOLD

Logo Axcelis Technologies Inc.

ACLS

Axcelis Technologies Inc.

HOLD

Current Price

$83.53

Market Cap

2.5B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
TXG
ACLS
Founded
2012
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Industrial Machinery/Components
Sector
Industrials
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.5B
IPO Year
2019
2000

Fundamental Metrics

Financial Performance
Metric
TXG
ACLS
Price
$21.98
$83.53
Analyst Decision
Hold
Buy
Analyst Count
14
4
Target Price
$16.82
$101.50
AVG Volume (30 Days)
2.6M
999.6K
Earning Date
05-06-2026
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
76.97
N/A
EPS
N/A
2.70
Revenue
$245,893,000.00
$1,017,865,000.00
Revenue This Year
N/A
$5.54
Revenue Next Year
$7.32
$1.72
P/E Ratio
N/A
$29.64
Revenue Growth
68.06
N/A
52 Week Low
$6.78
$40.40
52 Week High
$23.56
$102.93

Technical Indicators

Market Signals
Indicator
TXG
ACLS
Relative Strength Index (RSI) 64.85 46.68
Support Level $11.62 $78.05
Resistance Level $23.56 $85.84
Average True Range (ATR) 1.29 4.80
MACD 0.20 -0.77
Stochastic Oscillator 99.89 34.55

Price Performance

Historical Comparison
TXG
ACLS

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

About ACLS Axcelis Technologies Inc.

Axcelis Technologies Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. In addition to equipment, the company provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. Geographically, the group has a business presence in North America, Asia Pacific, and Europe, of which key revenue is derived from the Asia Pacific.

Share on Social Networks: